Shearman & Sterling represented Fleury S.A. in its initial public offering in the aggregate principal amount of US$312 million. Fleury is one of the leading businesses in the Brazilian health care industry, offering integrated services and solutions in diagnostic medicine and preventive and therapeutic medicine.

The following Shearman & Sterling team advised the company in the transaction: partner Robert Ellison (São Paulo) and associates Fabiana Sakai (São Paulo), Ana Absy (São Paulo) and Luciana Fraga (São Paulo).